Appraisal of lung cancer survival in patients with end-stage renal disease.

Arch Med Sci · 2023 · PMC9897077 · PMID 36817682

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although patients receiving surgical treatment compared to those receiving medical treatment had an improvement of survival by 46% (HR = 0.54, 95% CI: 0.19–1.53, p = 0.243), the difference did not reach statistical significance.

also in 111,027 other papers

marginally significantno p-value reported

However, a marginally significant median survival difference was noted for male patients without ESRD 11.56 months (95% CI: 8.77–14.19) compared to 6.31 months (3.71–8.51) for male patients with ESRD ( p = 0.059).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.